2,6-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 250mg

2-(3,5,5-Trimethylcyclohex-2-en-1-ylidene)malononitrile>98.0%(GC)5g

4'-Trifluoromethylbiphenyl-4-carbaldehyde, 95.0%, 25g

(2R)-2-(FMOC-AMINO)-5-HEXYNOIC ACID, 95%, 50mg

(2E)-3-(4-ethoxy-3-methoxyphenyl)acrylic acid, 95.0%, 250mg

1-(Piperidin-4-ylmethyl)-2,5-dihydro-1h-pyrrole-2,5-dione hydrochloride, 98%, 50mg

1-cyclopropyl-2-piperazin-1-ylethanone dihydrochloride, 95.0%, 250mg

(2S,5S)-5-Methylpyrrolidine-2-carboxylic acid hydrochloride, 98%, 1g

Methyl 3-amino-5-phenylthiophene-2-carboxylate, 97.0%, 100g

(R)-3-Amino-1-(3-(cyclohexylmethoxy)phenyl)propan-1-ol hydrochloride, 98.0%, 250mg

5-Fluoropyrimidine-2-carboxylic acid, 95.0%, 500mg

N-(Piperidin-4-yl)-4-(trifluoromethyl)benzamide hydrochloride, 1g

Methylhydroxyethyl cellulose, 3800-5300 mPas, powder, 250 g, plastic packaging.